Mimedx Group Inc (NASDAQ: MDXG) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Mimedx Group Inc is $1.22B. A total of 1.09 million shares were traded on the day, compared to an average of 640.41K shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, MDXG has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

In the most recent transaction, Whitlow Ricci S sold 61,420 shares of MDXG for 8.28 per share on Feb 13 ’25. After the transaction, the Chief Operating Officer now owns 403,019 company shares. In a previous transaction on Oct 10 ’24, GARDNER PHYLLIS bought 30,000 shares at 5.52 per share.

Among the insiders who sold shares, Hulse William Frank IV disposed of 20,381 shares on Mar 13 ’24 at a per-share price of $7.95. This resulted in the General Counsel and CAO holding 479,959 shares of MDXG after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for MDXG in the last 3 months, the mean price target is $13.40 with high estimates of $16.00 and low estimates of $12.00. In terms of 52-week highs and lows, MDXG has a high of $10.14 and a low of $5.47.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MDXG’s latest balance sheet shows that the firm has $87.08M in Cash & Short Term Investments as of fiscal 2021. There were $48.13M in debt and $42.36M in liabilities at the time. Its Book Value Per Share was $1.31, while its Total Shareholder’s Equity was $82.00k.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDXG is Buy with a score of 5.00.

Most Popular

Related Posts